Serveur d'exploration sur le saule

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Improving treatment for patients with childhood abuse related posttraumatic stress disorder (IMPACT study): protocol for a multicenter randomized trial comparing prolonged exposure with intensified prolonged exposure and phase-based treatment.

Identifieur interne : 000569 ( Main/Corpus ); précédent : 000568; suivant : 000570

Improving treatment for patients with childhood abuse related posttraumatic stress disorder (IMPACT study): protocol for a multicenter randomized trial comparing prolonged exposure with intensified prolonged exposure and phase-based treatment.

Auteurs : D A C. Oprel ; C M Hoeboer ; M. Schoorl ; R A De Kleine ; I G Wigard ; M. Cloitre ; A. Van Minnen ; W. Van Der Does

Source :

RBID : pubmed:30541492

English descriptors

Abstract

BACKGROUND

Childhood abuse related posttraumatic stress disorder (CA-PTSD) is associated with a high burden of disease and with treatment response rates that leave room for improvement. One of the treatments for PTSD, prolonged exposure (PE), is effective but has high drop-out rates and remission rates are relatively low. An intensified form of PE (iPE) was associated with good response and low drop-out rates in PTSD and has not yet been tested in a controlled trial in CA-PTSD. Phase-based treatment (PBT), in which PE is preceded by skills training may improve overall outcomes in this population. We will assess the effectiveness and cost-effectiveness of standard PE, iPE and PBT in patients with CA-PTSD.

METHODS/DESIGN

Multi-center randomized controlled trial. Treatment conditions are: prolonged exposure (PE; maximum of 16 sessions in 16 weeks); intensified PE (iPE; maximum of 12 sessions in four weeks and two booster sessions); phase-based treatment (PBT; maximum of eight sessions skills training followed by eight sessions PE in 16 weeks).

PRIMARY OUTCOME

Clinician-rated PTSD symptom severity.

SECONDARY OUTCOMES

loss of PTSD diagnosis, self-reported PTSD symptom severity, comorbid symptom severity and quality of life. Moreover, we will examine cost-effectiveness and moderators and mediators of treatment outcome.

TARGET POPULATION

adults with CA-PTSD (N = 150). Assessments in weeks 0, 4, 8, 16, 26 and 52.

DISCUSSION

Given that no consensus yet exists about the treatment guidelines for patients with CA-PTSD, the present study may have important implications for the treatment of CA-PTSD.

TRAIL REGISTRATION

Registered at C.C.M.O. on Sept 7, 2016 (NL57984.058.16); retrospectively registered at June 21, 2017 at clinicaltrials.gov identifier: NCT03194113 .


DOI: 10.1186/s12888-018-1967-5
PubMed: 30541492
PubMed Central: PMC6291949

Links to Exploration step

pubmed:30541492

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Improving treatment for patients with childhood abuse related posttraumatic stress disorder (IMPACT study): protocol for a multicenter randomized trial comparing prolonged exposure with intensified prolonged exposure and phase-based treatment.</title>
<author>
<name sortKey="Oprel, D A C" sort="Oprel, D A C" uniqKey="Oprel D" first="D A C" last="Oprel">D A C. Oprel</name>
<affiliation>
<nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hoeboer, C M" sort="Hoeboer, C M" uniqKey="Hoeboer C" first="C M" last="Hoeboer">C M Hoeboer</name>
<affiliation>
<nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Schoorl, M" sort="Schoorl, M" uniqKey="Schoorl M" first="M" last="Schoorl">M. Schoorl</name>
<affiliation>
<nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands. m.schoorl@fsw.leidenuniv.nl.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands. m.schoorl@fsw.leidenuniv.nl.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="De Kleine, R A" sort="De Kleine, R A" uniqKey="De Kleine R" first="R A" last="De Kleine">R A De Kleine</name>
<affiliation>
<nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wigard, I G" sort="Wigard, I G" uniqKey="Wigard I" first="I G" last="Wigard">I G Wigard</name>
<affiliation>
<nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Department of Clinical Psychology, University of Amsterdam, Overschiestraat 61, 1062, XD, Amsterdam, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cloitre, M" sort="Cloitre, M" uniqKey="Cloitre M" first="M" last="Cloitre">M. Cloitre</name>
<affiliation>
<nlm:affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, USA.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>National Center for PTSD Dissemination and Training Division, Palo Alto Veterans Affairs Palo Alto Health Care System, 795 Willow Road, Menlo Park, CA, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Van Minnen, A" sort="Van Minnen, A" uniqKey="Van Minnen A" first="A" last="Van Minnen">A. Van Minnen</name>
<affiliation>
<nlm:affiliation>PSYTREC, Prof. dr. Bronkhorststraat 2, 3723, MB, Bilthoven, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Radboud University, Behavioural Science Institute, Nijmegen, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Van Der Does, W" sort="Van Der Does, W" uniqKey="Van Der Does W" first="W" last="Van Der Does">W. Van Der Does</name>
<affiliation>
<nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:30541492</idno>
<idno type="pmid">30541492</idno>
<idno type="doi">10.1186/s12888-018-1967-5</idno>
<idno type="pmc">PMC6291949</idno>
<idno type="wicri:Area/Main/Corpus">000569</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000569</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Improving treatment for patients with childhood abuse related posttraumatic stress disorder (IMPACT study): protocol for a multicenter randomized trial comparing prolonged exposure with intensified prolonged exposure and phase-based treatment.</title>
<author>
<name sortKey="Oprel, D A C" sort="Oprel, D A C" uniqKey="Oprel D" first="D A C" last="Oprel">D A C. Oprel</name>
<affiliation>
<nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hoeboer, C M" sort="Hoeboer, C M" uniqKey="Hoeboer C" first="C M" last="Hoeboer">C M Hoeboer</name>
<affiliation>
<nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Schoorl, M" sort="Schoorl, M" uniqKey="Schoorl M" first="M" last="Schoorl">M. Schoorl</name>
<affiliation>
<nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands. m.schoorl@fsw.leidenuniv.nl.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands. m.schoorl@fsw.leidenuniv.nl.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="De Kleine, R A" sort="De Kleine, R A" uniqKey="De Kleine R" first="R A" last="De Kleine">R A De Kleine</name>
<affiliation>
<nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wigard, I G" sort="Wigard, I G" uniqKey="Wigard I" first="I G" last="Wigard">I G Wigard</name>
<affiliation>
<nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Department of Clinical Psychology, University of Amsterdam, Overschiestraat 61, 1062, XD, Amsterdam, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cloitre, M" sort="Cloitre, M" uniqKey="Cloitre M" first="M" last="Cloitre">M. Cloitre</name>
<affiliation>
<nlm:affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, USA.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>National Center for PTSD Dissemination and Training Division, Palo Alto Veterans Affairs Palo Alto Health Care System, 795 Willow Road, Menlo Park, CA, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Van Minnen, A" sort="Van Minnen, A" uniqKey="Van Minnen A" first="A" last="Van Minnen">A. Van Minnen</name>
<affiliation>
<nlm:affiliation>PSYTREC, Prof. dr. Bronkhorststraat 2, 3723, MB, Bilthoven, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Radboud University, Behavioural Science Institute, Nijmegen, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Van Der Does, W" sort="Van Der Does, W" uniqKey="Van Der Does W" first="W" last="Van Der Does">W. Van Der Does</name>
<affiliation>
<nlm:affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">BMC psychiatry</title>
<idno type="eISSN">1471-244X</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult (MeSH)</term>
<term>Adult Survivors of Child Abuse (psychology)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Implosive Therapy (methods)</term>
<term>Psychiatric Status Rating Scales (MeSH)</term>
<term>Quality of Life (MeSH)</term>
<term>Reproducibility of Results (MeSH)</term>
<term>Stress Disorders, Post-Traumatic (etiology)</term>
<term>Stress Disorders, Post-Traumatic (psychology)</term>
<term>Stress Disorders, Post-Traumatic (therapy)</term>
<term>Treatment Outcome (MeSH)</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Stress Disorders, Post-Traumatic</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Implosive Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en">
<term>Adult Survivors of Child Abuse</term>
<term>Stress Disorders, Post-Traumatic</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Stress Disorders, Post-Traumatic</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Psychiatric Status Rating Scales</term>
<term>Quality of Life</term>
<term>Reproducibility of Results</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>Childhood abuse related posttraumatic stress disorder (CA-PTSD) is associated with a high burden of disease and with treatment response rates that leave room for improvement. One of the treatments for PTSD, prolonged exposure (PE), is effective but has high drop-out rates and remission rates are relatively low. An intensified form of PE (iPE) was associated with good response and low drop-out rates in PTSD and has not yet been tested in a controlled trial in CA-PTSD. Phase-based treatment (PBT), in which PE is preceded by skills training may improve overall outcomes in this population. We will assess the effectiveness and cost-effectiveness of standard PE, iPE and PBT in patients with CA-PTSD.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS/DESIGN</b>
</p>
<p>Multi-center randomized controlled trial. Treatment conditions are: prolonged exposure (PE; maximum of 16 sessions in 16 weeks); intensified PE (iPE; maximum of 12 sessions in four weeks and two booster sessions); phase-based treatment (PBT; maximum of eight sessions skills training followed by eight sessions PE in 16 weeks).</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>PRIMARY OUTCOME</b>
</p>
<p>Clinician-rated PTSD symptom severity.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>SECONDARY OUTCOMES</b>
</p>
<p>loss of PTSD diagnosis, self-reported PTSD symptom severity, comorbid symptom severity and quality of life. Moreover, we will examine cost-effectiveness and moderators and mediators of treatment outcome.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>TARGET POPULATION</b>
</p>
<p>adults with CA-PTSD (N = 150). Assessments in weeks 0, 4, 8, 16, 26 and 52.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>DISCUSSION</b>
</p>
<p>Given that no consensus yet exists about the treatment guidelines for patients with CA-PTSD, the present study may have important implications for the treatment of CA-PTSD.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>TRAIL REGISTRATION</b>
</p>
<p>Registered at C.C.M.O. on Sept 7, 2016 (NL57984.058.16); retrospectively registered at June 21, 2017 at clinicaltrials.gov identifier: NCT03194113 .</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
<PMID Version="1">30541492</PMID>
<DateCompleted>
<Year>2019</Year>
<Month>09</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1471-244X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>18</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2018</Year>
<Month>12</Month>
<Day>12</Day>
</PubDate>
</JournalIssue>
<Title>BMC psychiatry</Title>
<ISOAbbreviation>BMC Psychiatry</ISOAbbreviation>
</Journal>
<ArticleTitle>Improving treatment for patients with childhood abuse related posttraumatic stress disorder (IMPACT study): protocol for a multicenter randomized trial comparing prolonged exposure with intensified prolonged exposure and phase-based treatment.</ArticleTitle>
<Pagination>
<MedlinePgn>385</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s12888-018-1967-5</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND">Childhood abuse related posttraumatic stress disorder (CA-PTSD) is associated with a high burden of disease and with treatment response rates that leave room for improvement. One of the treatments for PTSD, prolonged exposure (PE), is effective but has high drop-out rates and remission rates are relatively low. An intensified form of PE (iPE) was associated with good response and low drop-out rates in PTSD and has not yet been tested in a controlled trial in CA-PTSD. Phase-based treatment (PBT), in which PE is preceded by skills training may improve overall outcomes in this population. We will assess the effectiveness and cost-effectiveness of standard PE, iPE and PBT in patients with CA-PTSD.</AbstractText>
<AbstractText Label="METHODS/DESIGN">Multi-center randomized controlled trial. Treatment conditions are: prolonged exposure (PE; maximum of 16 sessions in 16 weeks); intensified PE (iPE; maximum of 12 sessions in four weeks and two booster sessions); phase-based treatment (PBT; maximum of eight sessions skills training followed by eight sessions PE in 16 weeks).</AbstractText>
<AbstractText Label="PRIMARY OUTCOME">Clinician-rated PTSD symptom severity.</AbstractText>
<AbstractText Label="SECONDARY OUTCOMES">loss of PTSD diagnosis, self-reported PTSD symptom severity, comorbid symptom severity and quality of life. Moreover, we will examine cost-effectiveness and moderators and mediators of treatment outcome.</AbstractText>
<AbstractText Label="TARGET POPULATION">adults with CA-PTSD (N = 150). Assessments in weeks 0, 4, 8, 16, 26 and 52.</AbstractText>
<AbstractText Label="DISCUSSION">Given that no consensus yet exists about the treatment guidelines for patients with CA-PTSD, the present study may have important implications for the treatment of CA-PTSD.</AbstractText>
<AbstractText Label="TRAIL REGISTRATION">Registered at C.C.M.O. on Sept 7, 2016 (NL57984.058.16); retrospectively registered at June 21, 2017 at clinicaltrials.gov identifier: NCT03194113 .</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Oprel</LastName>
<ForeName>D A C</ForeName>
<Initials>DAC</Initials>
<AffiliationInfo>
<Affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hoeboer</LastName>
<ForeName>C M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schoorl</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">0000-0002-6468-3934</Identifier>
<AffiliationInfo>
<Affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands. m.schoorl@fsw.leidenuniv.nl.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands. m.schoorl@fsw.leidenuniv.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>De Kleine</LastName>
<ForeName>R A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wigard</LastName>
<ForeName>I G</ForeName>
<Initials>IG</Initials>
<AffiliationInfo>
<Affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Clinical Psychology, University of Amsterdam, Overschiestraat 61, 1062, XD, Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cloitre</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>National Center for PTSD Dissemination and Training Division, Palo Alto Veterans Affairs Palo Alto Health Care System, 795 Willow Road, Menlo Park, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Van Minnen</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>PSYTREC, Prof. dr. Bronkhorststraat 2, 3723, MB, Bilthoven, The Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Radboud University, Behavioural Science Institute, Nijmegen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Van der Does</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Leiden University, Institute of Psychology, Wassenaarsweg 22, 3332, AK, Leiden, The Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Parnassiagroep, PsyQ, Lijnbaan 4, 2512, VA, The Hague, The Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT03194113</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2018</Year>
<Month>12</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>BMC Psychiatry</MedlineTA>
<NlmUniqueID>100968559</NlmUniqueID>
<ISSNLinking>1471-244X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054523" MajorTopicYN="N">Adult Survivors of Child Abuse</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007171" MajorTopicYN="N">Implosive Therapy</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013313" MajorTopicYN="Y">Stress Disorders, Post-Traumatic</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">CA-PTSD</Keyword>
<Keyword MajorTopicYN="Y">Childhood trauma</Keyword>
<Keyword MajorTopicYN="Y">Intensive treatment</Keyword>
<Keyword MajorTopicYN="Y">Phase-based treatment</Keyword>
<Keyword MajorTopicYN="Y">Posttraumatic stress disorder</Keyword>
<Keyword MajorTopicYN="Y">Prolonged exposure</Keyword>
<Keyword MajorTopicYN="Y">STAIR</Keyword>
<Keyword MajorTopicYN="Y">Trauma focused treatment</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2018</Year>
<Month>03</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2018</Year>
<Month>11</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>12</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2018</Year>
<Month>12</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>9</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">30541492</ArticleId>
<ArticleId IdType="doi">10.1186/s12888-018-1967-5</ArticleId>
<ArticleId IdType="pii">10.1186/s12888-018-1967-5</ArticleId>
<ArticleId IdType="pmc">PMC6291949</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Psychother Res. 2016 Sep;26(5):612-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26169837</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Depress Anxiety. 2016 May;33(5):357-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27115940</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Control Clin Trials. 2002 Oct;23(5):481-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12392862</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Health Qual Life Outcomes. 2013 Apr 12;11:59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23587015</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Child Abuse Negl. 2003 Feb;27(2):169-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12615092</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychol Assess. 2018 Mar;30(3):383-395</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28493729</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Child Psychol Psychiatry. 2017 Nov;58(11):1229-1238</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29057522</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2009 Jan 3;373(9657):68-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19056114</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Trauma Stress. 2010 Oct;23(5):537-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20839310</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Behav Res Ther. 2017 Nov;98:39-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27865431</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Behav Neurosci. 2015 Dec 24;9:351</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26733837</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9881538</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Gen Psychiatry. 1995 Dec;52(12):1048-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7492257</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Psychol Rev. 2017 Aug;56:106-121</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28734184</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Psychiatr Pract. 2014 Jan;20(1):25-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24419308</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Health Serv Res. 2013 Jun 15;13:217</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23768141</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Psychiatry. 2013 Jun;74(6):e541-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23842024</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Psychiatry. 2014 Mar;171(3):294-304</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24480899</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Psychiatry Rep. 2015 Mar;17(3):549</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25736701</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Biom Biostat. 2013 Jul 5;1(1):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25045756</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Psychiatry. 2005 Feb;162(2):214-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15677582</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Psychiatr Res. 2006 Feb;40(1):1-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16242154</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Psychol Rev. 2014 Dec;34(8):645-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25455628</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Tijdschr Gerontol Geriatr. 1992 Aug;23(4):132-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1412616</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pers. 2011 Feb;79(1):2-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21223263</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Psychotraumatol. 2014 Sep 15;5:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25279111</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Behav Res Ther. 2002 Apr;40(4):439-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12002900</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11132119</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Consult Clin Psychol. 2002 Oct;70(5):1067-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12362957</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pers Soc Psychol. 2005 Oct;89(4):623-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16287423</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cogn Emot. 2014 Apr;28(3):433-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24044520</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med Care. 2013 Dec;51(12):1114-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24226308</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Trauma Stress. 2015 Dec;28(6):489-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26606250</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychother Res. 2002 Mar 1;12(1):79-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22471333</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychol Med. 2017 Jun;47(8):1370-1378</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28052776</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014 Jan 08;9(1):e83875</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24416178</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Psychiatry. 2010 Jun;167(6):640-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20360318</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ment Health Serv Res. 2005 Jun;7(2):89-101</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15974155</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Psychiatry. 2010 Aug;167(8):915-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20595411</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychol Rep. 2001 Dec;89(3):595-606</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11824722</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Child Abuse Negl. 2009 Aug;33(8):518-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19758699</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychol Assess. 2017 Feb;29(2):158-171</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27148789</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Nerv Ment Dis. 1986 Dec;174(12):727-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3783140</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Psychotraumatol. 2018 Jan 30;9(1):1425574</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29410776</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Psychol Med Settings. 2013 Mar;20(1):37-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22802144</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Gen Psychiatry. 1999 Jul;56(7):600-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10401504</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Assessment. 2004 Dec;11(4):330-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15486169</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2018 Jan 23;319(4):354-364</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29362795</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Consult Clin Psychol. 2004 Jun;72(3):411-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15279525</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Depress Anxiety. 2016 Mar;33(3):247-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26882293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2001 Aug 11;358(9280):450-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11513908</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pers Disord. 2003 Dec;17(6):562-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14744081</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Depress Anxiety. 2016 May;33(5):359-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26840244</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2016 Oct 10;11(10):e0161645</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27723815</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 2012 Jun 1;71(11):962-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22480663</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Behav Res Ther. 2006 Jul;44(7):1053-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16169513</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Psychotraumatol. 2018 Feb 06;9(1):1430962</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29441153</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Psychotraumatol. 2014 Oct 14;5:23613</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25563302</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychol Assess. 2006 Mar;18(1):112-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16594820</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Clin Psychol. 1996 Feb;35(1):21-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8673033</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Stat Med. 2014 Jan 30;33(2):219-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23922224</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Trauma Stress. 2005 Oct;18(5):425-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16281240</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Consult Clin Psychol. 2013 Jun;81(3):394-404</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23339535</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Psychol. 2016 Sep;72(9):933-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27018649</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2012;9(11):e1001349</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23209385</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Interpers Violence. 2016 Nov;31(18):3063-3079</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25948645</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Psychol Rev. 2015 Jun;38:39-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25795293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Child Abuse Negl. 2009 Oct;33(10):666-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19811826</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/WillowV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000569 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000569 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    WillowV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:30541492
   |texte=   Improving treatment for patients with childhood abuse related posttraumatic stress disorder (IMPACT study): protocol for a multicenter randomized trial comparing prolonged exposure with intensified prolonged exposure and phase-based treatment.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:30541492" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a WillowV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Nov 17 16:35:40 2020. Site generation: Tue Nov 17 16:39:32 2020